Beta-cryptoxanthin and lung cancer in Shanghai, China--an examination of potential confounding with cigarette smoking using urinary cotinine as a biomarker for true tobacco exposure.
about
Can we use biomarkers in combination with self-reports to strengthen the analysis of nutritional epidemiologic studies?Toenail nicotine level as a novel biomarker for lung cancer risk.Cytochrome P4501A2 phenotype and bladder cancer risk: The Shanghai bladder cancer study.Citrus nobiletin suppresses bone loss in ovariectomized ddY mice and collagen-induced arthritis in DBA/1J mice: possible involvement of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclastogenesis regulation.
P2860
Beta-cryptoxanthin and lung cancer in Shanghai, China--an examination of potential confounding with cigarette smoking using urinary cotinine as a biomarker for true tobacco exposure.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Beta-cryptoxanthin and lung ca ...... ker for true tobacco exposure.
@en
type
label
Beta-cryptoxanthin and lung ca ...... ker for true tobacco exposure.
@en
prefLabel
Beta-cryptoxanthin and lung ca ...... ker for true tobacco exposure.
@en
P2093
P2860
P1433
P1476
Beta-cryptoxanthin and lung ca ...... ker for true tobacco exposure.
@en
P2093
Daniel O Stram
Jian-Min Yuan
Kenneth K Chan
Ronald K Ross
P2860
P304
P356
10.1080/01635580701273998
P50
P577
2007-01-01T00:00:00Z